Nanomedicine News

RSS

Arrowhead Opens New Nanomedicine Company to Commercicalize Anti-Obesity Technology

Arrowhead Research Corporation today announced that it has executed an exclusive world-wide license on technology developed by Drs. Wadih Arap and Renata Pasqualini at MD Anderson Cancer Center for use in weight loss and obesity-related metabolic conditions, and that it has launched a new company, Ablaris Therapeutics Inc., to commercialize this platform.

From Arrowhead Pharmaceutical 21 Dec 2010

German Center for Research and Innovation Discusses Developments in Plasma Medicine

A panel discussion on new developments in plasma medicine in Germany and the United States There are currently 42 plasma medicine research groups worldwide, and two of the four leading groups are located in Germany (M...

20 Dec 2010

Marburg Researchers Develop Technique to Produce Thin Polymer Fibres at Nanoscale

Three-dimensional frameworks where cells can settle and grow tissues and organs are desired in the regenerative medicine. Material scientists of the University Würzburg have now developed new scaffolds with very spe...

20 Dec 2010

Imec Derives Process Flow Concept for Packaging of Medical Implants

Imec has derived a process flow concept for the packaging of medical implants that meets the requirements for miniaturization, biocompatibility and safety. The proposed solution is a promising alternative for the currently used rigid packages that tend to enhance foreign body reactions.

From IMEC 17 Dec 2010

Two Powerful Anticancer Agents in One Polymer Nanoparticle Producing Substantial Boost in Destroying Tumors

The standard approach to cancer therapy today is to mix and match chemotherapy drugs in order to attack tumors in multiple ways. Now, two separate teams of investigators have demonstrated that using nanoparticles to deli...

17 Dec 2010

Tracking Delivery of Therapeutic Nanoparticle to Breast Tumor

Researchers at Rice University, collaborating with investigators at the Baylor College of Medicine, have used two different types of imaging technologies to track the delivery of a therapeutic nanoparticle to breast tumo...

17 Dec 2010

Microsensor to Answer One of the Weightiest Questions in Biology

Researchers at the University of Illinois, Urbana-Champaign, have developed a new kind of microsensor to answer one of the weightiest questions in biology – the relationship between cell mass and growth rate. The team, led by Rashid Bashir, published its results in the Proceedings of the National Academy of Sciences.

17 Dec 2010

Research Team Creates "Nanobioconjugate" Drug to Target Brain Tumors

Nine years ago, scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute detected a subtle shift occurring in the molecular makeup of the most aggressive type of brain tumors, glioblastoma multiforme. With ...

17 Dec 2010

Geometrical Confinement of Gadolinium-Based Contrast Agents in Nanoporous Particles Enhances T1 Contrast

A porous, disk-shaped "nest" for nanotubes may help magnetic resonance imaging become better than ever at finding evidence of cancer if the results of research led by investigators at Rice University are any in...

17 Dec 2010

NanoLogix Conducts GBS Quick-Tests at University of Texas Health Science Center

NanoLogix an innovator in the accelerated detection and identification of microorganisms, announces the current 300 patient trial of NanoLogix GBS (Group B Streptococcus) Quick Tests is ongoing at the University of Texas Health Science Center (UTHSC) in Houston.

From NanoLogix 14 Dec 2010